Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis-Reference-Cited by-同舟云学术

Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis

Published:2020-03-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hanna Catherine¹,Lawrie Theresa A²,Rogozińska Ewelina²,Kernohan Ashleigh³,Jefferies Sarah⁴,Bulbeck Helen⁵,Ali Usama M⁶,Robinson Tomos³,Grant Robin⁷

Affiliation:

1. University of Glasgow; Department of Oncology; Beatson West of Scotland Cancer Centre Great Western Road Glasgow Scotland UK G4 9DL

2. The Evidence-Based Medicine Consultancy Ltd; 3rd Floor Northgate House Upper Borough Walls Bath UK BA1 1RG

3. Newcastle University; Institute of Health & Society; Baddiley-Clark Building, Richardson Road Newcastle upon Tyne UK NE2 4AA

4. Addenbrooke's Hospital; Department of Oncology; Hills Road Cambridge UK CB2 0QQ

5. brainstrust; Director of Services; 4 Yvery Court Castle Road Cowes Isle of Wight UK PO31 7QG

6. University of Oxford; Nuffield Department of Population Health; Roosevelt Drive Old Road Campus Oxford Oxfordshire UK OX3 7LF

7. Western General Hospital; Edinburgh Centre for Neuro-Oncology (ECNO); Crewe Road Edinburgh Scotland UK EH4 2XU

Publisher

Wiley

Subject

Pharmacology (medical)

Reference267 articles.

1. Weller M Tabatabai G Roelcke U Hottinger A Joeger F Schmid A The randomized phase II ARTE trial: Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with newly diagnosed globlastoma Journal of Neuro-oncology. Official Journal of the Society of Neuro-Oncology 22nd Annual Scientific Meeting 16-19 November 2017 2017

2. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the arte trial;Wirsching;Journal of Neuro-oncology. Conference: 5th quadrennial meeting of the world federation of neuro-oncology societies, WFNOS. Switzerland,2017

3. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, Phase II ARTE trial;Wirsching;Annals of Oncology,2018

4. Upfront bevacizumab may extend survival for glioblastoma patients WHO do not receive second-line therapy: an exploratory analysis of AVAglio;Chinot;Journal of Neuro-oncology,2016

5. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma;Chinot;New England Journal of Medicine,2014

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors affecting the survival of patients with glioblastoma treated with standard and hypofractionated radiation regimens;Український радіологічний та онкологічний журнал;2023-12-29

2. Neuro-oncology Treatment Strategies for Primary Glial Tumors;Seminars in Neurology;2023-12

3. How do network meta-analyses address intransitivity when assessing certainty of evidence: a systematic survey;BMJ Open;2023-11

4. Survival of elderly patients with glioblastoma after hypofractionated radiation therapy;Український радіологічний та онкологічний журнал;2023-09-30

5. Clinical effects of a traditional Chinese medicine nursing programme to intervene in gastric pain of the spleen and stomach with Qi deficiency;World Journal of Clinical Cases;2023-07-26